Asia Pacific ELISA Diagnostics Tests Market Forecast to 2030

Asia Pacific ELISA Diagnostics Tests Market Forecast to 2030

Asia Pacific ELISA Diagnostics Tests Market Forecast to 2030 – Regional Analysis – by Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), and End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others)

Send Enquiry
Item ID: BMIRE00029816 Category: Tag:

$2,485 – $3,885

Description

The Asia Pacific ELISA diagnostics tests market was valued at US$ 255.70 million in 2022 and is expected to reach US$ 503.08 million by 2030; it is estimated to grow at a CAGR of 8.8% from 2022 to 2030.

Innovative Product Launches Bolster Asia Pacific ELISA Diagnostics Tests Market

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities. Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. “Human Factor IX Kit” is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests. Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans. In December 2022, Pictor Limited announced a new product launch of the “PictArray SARS-CoV-2 Antibody Test,” which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Asia Pacific ELISA Diagnostics Tests Market Overview

China has a strong and resilient public health system that can rapidly prevent, detect, and respond to infectious disease threats before they become epidemics. China’s ecology poses a risk for emerging, re-emerging, and novel diseases that could threaten China and the Rest of world owing to the vast population of ~ 1.4 billion and 50% of the world’s livestock. In an article published by Journal of Global Health in September 2023, a study was carried out on annual incidence and fatality rates of notifiable infectious diseases in Jiangsu province of southeast China. The study concluded that public health policies have been effective in reducing the incidence of intestinal, vector-borne, and zoonotic diseases during the study period and the associated fatality, but that the incidence of sexually transmitted and blood-borne diseases, mainly syphilis and AIDS, has increased.

Additionally, growing network of air travel routes across the world dramatically increases the risk of rapid infection spread, including infections that may lead to pandemics, such as the COVID-19 pandemic, that result in disruption of global trade, rise in illness cases, or increase in deaths. The country is expected to provide lucrative opportunities to local and international players involved in ELISA diagnostics test market in the country.

Asia Pacific ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific ELISA Diagnostics Tests Market Segmentation

The Asia Pacific ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Asia Pacific ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Asia Pacific ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Asia Pacific ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Asia Pacific ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Asia Pacific ELISA diagnostics tests market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the Asia Pacific ELISA diagnostics tests market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

, ,

Year of Publication:

At 8.8% CAGR, the Asia Pacific ELISA Diagnostics Tests Market is Speculated to be worth US$ 503.08 million by 2030, Says the Research Team

According to the Research Team’ research, the Asia Pacific ELISA diagnostics tests market was valued at US$ 255.70 million in 2022 and is expected to reach US$ 503.08 million by 2030, registering a CAGR of 8.8% from 2022 to 2030. Increasing incidence of human infections and innovative product launches are among the critical factors attributed to the Asia Pacific ELISA diagnostics tests market expansion.

According to the WHO Report 2020, noncommunicable and chronic diseases cause the majority of adult deaths worldwide. Over the next ten years, this number is expected to rise by 17%. Roughly one in three persons worldwide deal with several chronic illnesses. Moreover, noncommunicable illnesses account for 41 million annual deaths worldwide, or 74% of all fatalities. Further, 17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities. With 17.9 million fatalities from NCDs each year, cardiovascular illnesses account for the majority of mortality. Cancer, chronic respiratory diseases, and diabetes follow closely behind. In humans, ELISA test is used as a biomarker to detect cancer, infectious diseases, autoimmunity, endocrinology diagnosis, immunology & cytokines, cell adhesion molecules (CAMs), and others. ELISA testing helps detect cancer at the early stage of diagnostic processes, offering a better chance for patient survival and getting appropriate treatment initially. Therefore, demand for ELISA testing is high across the world owing resulting in market growth during the forecast period.

On the contrary, incidents of product recalls hamper the growth of Asia Pacific ELISA diagnostics tests market.

Based on adoption, the Asia Pacific ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held 64.9% market share in 2022, amassing US$ 166.00 million. It is projected to garner US$ 338.84 million by 2030 to expand at 9.3% CAGR during 2022-2030.

In terms of test type, the Asia Pacific ELISA diagnostics tests market is categorized into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held 35.3% share of Asia Pacific ELISA diagnostics tests market in 2022, amassing US$ 90.36 million. It is projected to garner US$ 194.82 million by 2030 to expand at 10.1% CAGR during 2022-2030.

Based on application, the Asia Pacific ELISA diagnostics tests market is categorized into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held 41.2% share of Asia Pacific ELISA diagnostics tests market in 2022, amassing US$ 105.36 million. It is projected to garner US$ 224.47 million by 2030 to expand at 9.9% CAGR during 2022-2030.

By end user, the Asia Pacific ELISA diagnostics tests market is categorized into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held 40.3% share of Asia Pacific ELISA diagnostics tests market in 2022, amassing US$ 103.08 million. It is projected to garner US$ 217.28 million by 2030 to expand at 9.8% CAGR during 2022-2030.

Based on country, the Asia Pacific ELISA diagnostics tests market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 60.4% share of Asia Pacific ELISA diagnostics tests market in 2022. It was assessed at US$ 154.47 million in 2022 and is likely to hit US$ 317.19 million by 2030, exhibiting a CAGR of 9.4% during 2022-2030.

Key players operating in the Asia Pacific ELISA diagnostics tests market are Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp., among others.

In June 2022, Biotech Firm Tackling COVID-19 and M. bovis announces successful development of rapid, accurate Johnes Diseases Assay.

In Feb 2020, Bio-Techne Corp launched next generation ELISA kits.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific ELISA diagnostics tests market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific ELISA diagnostics tests market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific ELISA diagnostics tests market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
1.2.1 Asia Pacific ELISA Diagnostic Tests Market – by Adoption
1.2.2 Asia Pacific ELISA Diagnostic Tests Market – by Test Type
1.2.3 Asia Pacific ELISA Diagnostic Tests Market – by Application
1.2.4 Asia Pacific ELISA Diagnostic Tests Market – by End User
1.2.5 Asia Pacific ELISA Diagnostic Tests Market – by Country
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific ELISA Diagnostic Test Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Infectious Diseases Among Animals
4.1.2 Increasing Incidence of Human Infections
4.2 Key Market Restraints
4.2.1 Incidents of Product Recalls
4.3 Key Market Opportunities
4.3.1 Innovative Product Launches
4.4 Future Trends
4.4.1 Advancements in ELISA-Based Procedures
5. ELISA Diagnostic Tests Market – Asia Pacific Market Analysis
5.1 Overview
5.2 Asia Pacific ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Adoption
6.1 Overview
6.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
6.3 Human
6.3.1 Overview
6.3.2 Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Veterinary
6.4.1 Overview
6.4.2 Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Sandwich ELISA
7.3.1 Overview
7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Indirect ELISA
7.4.1 Overview
7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Competitive ELISA
7.5.1 Overview
7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Multiple & Portable ELISA
7.6.1 Overview
7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Autoimmune Diseases
8.3.1 Overview
8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Infectious Disease
8.4.1 Overview
8.4.2 Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Cancer Diagnosis
8.5.1 Overview
8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Protein Quantification
8.6.1 Overview
8.6.2 Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Veterinary Hospitals & Diagnostic Laboratories
9.5.1 Overview
9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Asia Pacific: ELISA Diagnostic Tests Market
10.1.1 Asia Pacific: ELISA Diagnostic Tests Market, by Country
10.1.1.1 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
10.1.1.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11. ELISA Diagnostics Test Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in ELISA diagnostics test Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Bio-Rad Laboratories Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Idexx Laboratories Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Danaher Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pictor Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin SpA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Elabscience Biotechnology Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.10 Bio-Techne Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. ELISA Diagnostic Test Market Segmentation
Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
Table 3. China ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 4. China ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. China ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. China ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. India ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 12. India ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. India ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 14. India ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. South Korea ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of Asia Pacific ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 27. Recent Organic Growth Strategies in ELISA diagnostics Test Market
Table 28. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
Table 29. Glossary of Terms, ELISA Diagnostic Tests Market

LIST OF FIGURES

Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 – 2030
Figure 5. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
Figure 6. Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific: ELISA Diagnostic Tests Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. Asia Pacific: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 26. China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in ELISA diagnostics test Market

The List of Companies – Asia Pacific ELISA Diagnostics Tests Market

1. Bio-Rad Laboratories Inc.
2. Idexx Laboratories Inc.
3. F. Hoffmann-La Roche Ltd.
4. Thermo Fisher Scientific Inc.
5. Abbott Laboratories
6. Danaher Corp.
7. Pictor Ltd.
8. DiaSorin SpA
9. Elabscience Biotechnology Inc.
10. Bio-Techne Corp.

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific ELISA Diagnostics Tests Market Forecast to 2030”